SCHEMBL20078126

SCHEMBL20078126

CNc1ccccc1N(C)c1nc(N2CCOCC2)nc(N2CCC(=O)CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ PIK3CB P42338 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ HTT P42858 3/20 0.41
▸ PKM P14618 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PIK3CA P42336 4/20 0.39
▸ MTOR P42345 2/20 0.39
▸ PIK3CG P48736 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ PIK3R1 P27986 1/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20078117 0.85 LMNA (0.46) LMNATSHRPIK3CBPOLBHTT
SCHEMBL21183024 0.75 PKM (0.45) LMNATSHRPIK3CBHTTPKM
SCHEMBL20078073 0.67 PIK3CB (0.52) LMNAPIK3CBPOLBHTTPIK3CA
SCHEMBL8537283 0.65 LMNA (0.61) LMNATSHRPOLBHTTPKM
SCHEMBL6625296 0.65 PIK3CB (0.83) PIK3CBHTTPIK3CAMTORPIK3CG
SCHEMBL15386558 0.64 PIK3CA (0.80) PIK3CBPIK3CAMTORPIK3CGPIK3R1
SCHEMBL8342797 0.63 ALDH1A1 (0.55) LMNATSHRPOLBPKMALDH1A1
SCHEMBL1444931 0.63 TSHR (0.81) LMNATSHRPOLBHTTPKM
SCHEMBL19654590 0.62 LMNA (0.53) LMNATSHRPOLBHTTPKM
SCHEMBL29592399 0.62 PIK3CA (0.84) PIK3CBPIK3CAMTORPIK3CGPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221307-B1 NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2019-07-24 — — EP disclosed
US-9951040-B2 1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-04-24 — — US disclosed
Send feedback